CRISPR/Cas9 deletion of MIR155HG in human T cells reduces incidence and severity of acute GVHD in a xenogeneic model
Neidemire-Colley, Lotus, Khanal, Shrijan, Braunreiter, Kara M., Gao, Yandi, Kumar, Rathan, Snyder, Katiri J., Weber, Margot A., Surana, Simran, Toirov, Olimjon, Karunasiri, Malith, Duszynski, Molly E., Chi, Mengna, Malik, Punam, Kalyan, Sonu, Chan, Wing K., Naeimi Kararoudi, Meisam, Choe, Hannah K., Garzon, Ramiro, Ranganathan, Parvathi
Published in Blood advances (27.02.2024)
Published in Blood advances (27.02.2024)
Get full text
Journal Article